Fidelity International
ABMD

Fidelity International’s Abiomed Inc ABMD Stock Holding History

Fidelity International’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$1K – 1139
2021
Q1 		$1K Hold
2
– – ﹤0.01% 963
2020
Q4 		$1K Sell
2
-15
-88% -$4.15K ﹤0.01% 928
2020
Q3 		$5K Hold
17
– – ﹤0.01% 791
2020
Q2 		$4K Buy
17
+2
+13% +$402 ﹤0.01% 786
2020
Q1 		$2K Hold
15
– – ﹤0.01% 753
2019
Q4 		$3K Hold
15
– – ﹤0.01% 794
2019
Q3 		$3K Sell
15
-1
-6% -$216 ﹤0.01% 751
2019
Q2 		$4K Sell
16
-49,574
-100% -$13.2M ﹤0.01% 745
2019
Q1 		$14.2M Buy
49,590
+6,004
+14% +$2M 0.02% 403
2018
Q4 		$14.2M Sell
43,586
-17,798
-29% -$6.18M 0.03% 396
2018
Q3 		$27.6M Sell
61,384
-8,454
-12% -$3.33M 0.04% 346
2018
Q2 		$28.6M Sell
69,838
-24,379
-26% -$8.83M 0.04% 335
2018
Q1 		$27.4M Buy
+94,217
New +$23.9M 0.08% 225

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity International's ABMD Position: Q2 2021 in Review

Fidelity International sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 2 shares — an estimated $1K sold.

Fidelity International first reported a position in ABMD in Q1 2018 and held it in 13 quarters. The position peaked at $28.6M in Q2 2018. 475 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Fidelity International reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Fidelity International sold 2 Abiomed Inc shares in Q2 2021, an estimated $1K.
  • Fidelity International first reported a position in Abiomed Inc in Q1 2018 and held it in 13 quarters.
  • Fidelity International's Abiomed Inc position peaked at $28.6M in Q2 2018.
  • 475 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Fidelity International's 13F filing for Q2 2021, filed 13 Aug 2021.